Senti Biosciences Inc.
SNTI | NASDAQ
$0.46
$0.00 (+0.07%)
Nov 2, 2026, 12:30 PM ET · Market open
Market Data
Market Cap $12.09M
Enterprise Value $22.29M
Beta 2.05
Average Volume 198.36K
Shares Outstanding (Diluted) 30.97M
Shares Change YoY 573.89%
Institutional Ownership N/A
Exchange NASDAQ
ISIN US8169441024
Price Performance
Price Change 1M -52.1%
Price Change 3M -58.2%
Price Change 6M -57.0%
Price Change YTD -58.2%
Price Change 1Y -76.7%
Price Change 3Y -94.8%
Price Change 5Y -99.5%
1M CAGR (ann.) -40.5%
1Y CAGR (ann.) -70.4%
5Y CAGR (ann.) -64.2%
All-Time CAGR -63.2%
Valuation
PE Ratio -0.24
Forward PE N/A
PEG Ratio -0.00
Forward PEG N/A
PS Ratio 549.36
Forward PS 120.90
PB Ratio 4.71
P/FCF Ratio -0.33
P/Adj. FCF Ratio -0.29
P/OCF Ratio -0.39
EV/Sales 1,013.27
EV/EBIT -0.48
EV/EBITDA -0.47
EV/FCF -0.60
Earnings Yield -417.4%
FCF Yield -306.7%
Adj. FCF Yield -342.0%
Financial Health
Net Cash $3.04M
Total Debt $19.14M
Cash & Short-Term Investments $8.94M
Total Assets $38.24M
Current Ratio 1.04
Quick Ratio 1.04
Debt / Equity Ratio 7.46
Debt / EBITDA -0.40
Debt / FCF -0.52
OCF / Debt -1.93
Interest Coverage 0.00
Altman Z-Score -17.01
Piotroski F-Score 2
Margins & Profitability
Gross Profit Margin -8513.2%
Operating Profit Margin -236118.2%
EBITDA Margin -125823.7%
Net Profit Margin -135650.0%
FCF Margin -168504.5%
Adj. FCF Margin -187895.5%
SBC / Revenue 15307.9%
SBC Impact (per share) -11.5%
Returns
Return on Assets -134.8%
Return on Equity -503.8%
Return on Invested Capital -197.0%
Return on Capital Employed -245.4%
Return on Tangible Assets -134.8%
Historical Growth (CAGR)
Revenue CAGR 3Y -81.2%
Revenue CAGR 5Y -43.9%
Revenue CAGR 10Y N/A
EPS CAGR 3Y 26.5%
EPS CAGR 5Y 8.0%
EPS CAGR 10Y N/A
FCF CAGR 3Y 14.3%
FCF CAGR 5Y -14.4%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Buy
Analyst Count 4
EPS Growth Next 3Y 16.8%
Revenue Growth Next 3Y 1271.9%
Earnings Date Aug 6, 2026
EPS Estimate (next Q) -$0.33
EPS Growth Est (next Q) -41.1%
Revenue Est (next Q) $14.93K
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $6.00
Price Target Upside 1204.3%
Cash Flow
Operating Cash Flow $-36.88M
Free Cash Flow $-37.07M
Adj. Free Cash Flow $-41.34M
FCF Per Share -$1.20
OCF Per Share -$1.19
OCF/S Ratio -97039.5%
Income Statement
Revenue $22K
Gross Profit $-3.25M
Operating Income $-51.95M
EBITDA $-47.79M
Net Income $-51.55M
EPS (Diluted) -$1.92
Revenue / Employee $647.06
Profit / Employee $-1.52M
Employees 34
Add to Watchlist
Select watchlists to add or remove SNTI